Literature DB >> 30520938

Incorrect Treatment Group in Results and Error in Legend of Figure 2.

.   

Abstract

Year:  2019        PMID： 30520938      PMCID： PMC8177400          DOI： 10.1001/jamaoncol.2018.6113

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  1 in total

1.  Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial.

Authors:  Paolo A Ascierto; Georgina V Long; Caroline Robert; Benjamin Brady; Caroline Dutriaux; Anna Maria Di Giacomo; Laurent Mortier; Jessica C Hassel; Piotr Rutkowski; Catriona McNeil; Ewa Kalinka-Warzocha; Kerry J Savage; Micaela M Hernberg; Celeste Lebbé; Julie Charles; Catalin Mihalcioiu; Vanna Chiarion-Sileni; Cornelia Mauch; Francesco Cognetti; Lars Ny; Ana Arance; Inge Marie Svane; Dirk Schadendorf; Helen Gogas; Abdel Saci; Joel Jiang; Jasmine Rizzo; Victoria Atkinson
Journal:  JAMA Oncol       Date:  2019-02-01       Impact factor: 31.777
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.